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The gram-negative bacterium Escherichia coli is the leading cause of urinary tract infection. The interaction
between type 1 piliated E. coli and bladder epithelial cells leads to the rapid production of inflammatory
mediators, such as interleukin-6 (IL-6) and IL-8. Conflicting reports have been published in the literature
regarding the mechanism by which uroepithelial cells are activated by type 1 piliated E. coli. In particular, the
role of lipopolysaccharide (LPS) in these responses has been an area of significant debate. Much of the data
arguing against LPS-mediated activation of bladder epithelial cells have come from studies using a renal
epithelial cell line as an in vitro model of the urinary epithelium. In this report, we analyzed three bladder
epithelial cell lines and demonstrated that they all respond to LPS. Furthermore, the LPS responsivity of the
cell lines directly correlated with their ability to generate IL-6 after E. coli stimulation. The LPS receptor
complex utilized by the bladder epithelial cell lines included CD14 and Toll-like receptors, and signaling
involved the activation of NF-B and p38 mitogen-activated protein kinase. Also, reverse transcription-PCR
analysis demonstrated that bladder epithelial cells express CD14 mRNA. Thus, the molecular machinery
utilized by bladder epithelial cells for the recognition of E. coli is very similar to that described for traditional
innate immune cells, such as macrophages. In contrast, the A498 renal epithelial cell line did not express
CD14, was hyporesponsive to LPS stimulation, and demonstrated poor IL-6 responses to E. coli.
In order for a pathogen to cause disease at a mucosal sur-
face, it must be able to adhere to host epithelial cells, estab-
lishing a focus of infection. This places epithelial cells in a
unique position at the forefront of innate host defense. In
addition to functioning as a barrier to pathogen entry, epithe-
lial cells also play an active role in host defense through the
production of cytokines, chemokines, and antimicrobial pep-
tides (28). It is likely that the early interaction between bacteria
and epithelial cells is a critical determinant in the outcome of
an infection. In spite of this fact, the receptors utilized by
epithelial cells to recognize pathogens and to initiate an-
tipathogen responses are not completely understood.
The well-established in vitro and in vivo models for the
interaction between Escherichia coli and uroepithelial cells
make this system ideal for the investigation of pathogen rec-
ognition by epithelial cells. The ability of uropathogenic E. coli
(UPEC) to establish infection in the urinary tract depends on
its ability to express surface-adhesive organelles that facilitate
colonization of the uroepithelium. P pili are produced by py-
elonephritic strains of E. coli and mediate binding to globo-
series glycolipids that predominate in the kidney (22). Conse-
quently, P pili have been shown to be critical in the ability of E.
coli to cause pyelonephritis (42). Type 1 pili bind to mannose-
containing glycoproteins present on the bladder epithelial sur-
face and are critical in the establishment of cystitis (31, 36).
Type 1 pili are under an on-off phase variation control (6), and
colonization of the bladder selects for type 1 piliated phase
variants (11, 23).
Despite the distinct receptor specificities of P and type 1 pili,
E. coli strains expressing either of these adhesive organelles
have been demonstrated to augment bladder and kidney epi-
thelial cell cytokine production compared to isogenic nonpili-
ated strains (14, 44). However, bacterial attachment mediated
by these different adhesive pili results in the activation of
distinct signaling pathways (16). The binding of P-piliated E.
coli to globoside receptors present on kidney epithelial cells
appears to activate interleukin-6 (IL-6) and IL-8 production
via a predominantly lipopolysaccharide (LPS)-independent
mechanism (7, 17). The role of Toll-like receptor 4 (TLR4) in
this process is controversial. It has been reported that the
LPS-independent activation of cytokine induction in kidney
epithelial cells is TLR4 dependent (7, 17). In contrast, TLR4
has also been reported to be missing in kidney epithelial cells
(3). The mechanism of activation of bladder epithelial cells by
type 1 piliated E. coli is equally confusing. Several reports have
argued that type 1 pili directly activate uroepithelial cytokine
production and that LPS plays only a minor role (15, 47).
These conclusions were based in large part on studies with
A498 kidney cells. However, studies with bladder epithelial
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Washington University School of Medicine, 660 S. Eu-
clid Ave., Campus Box 8230, Saint Louis, MO 63110-1093. Phone:
(314) 362-6772. Fax: (314) 362-1998. E-mail: hultgren@borcim.wustl
.edu.
† Present address: Department of Pathology, University of Alabama
at Birmingham, Birmingham, AL 35294.
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cells demonstrated that LPS is the primary bacterial factor
activating cytokine production and that the role of type 1 pili is
to augment the presentation of LPS to the LPS receptor com-
plex on the bladder epithelial cells (3, 44). Thus, the discrep-
ancies regarding the roles of type 1 pili and LPS in bladder cell
activation may be explained by differences in the cell lines
utilized for analysis.
LPS is the predominant component of the outer membrane
of gram-negative bacteria, and its recognition by host cells
requires an array of proteins. LPS-binding protein (LBP) and
soluble CD14 (sCD14) are present in the serum and facilitate
the transfer of LPS to membrane-bound CD14 (mCD14), a
glycosylphosphatidylinositol-linked receptor on the surfaces of
some host cells (24). It is thought that mCD14 subsequently
interacts with TLR4, the signaling component of the LPS re-
ceptor (4). A secreted molecule known as MD-2 physically
interacts with the extracellular domain of TLR4 and signifi-
cantly enhances host cell responses to LPS (45, 51). TLR2 has
also been reported to interact with certain lipid A structures, as
well as with the lipoproteins that are intimately associated with
LPS (18, 19). In host cells lacking expression of mCD14,
sCD14 can partially compensate for the absence of this recep-
tor under some circumstances (13, 32). Investigators using
A498 cells as a model have reported that uroepithelial cells are
CD14 negative (3, 15) and thus hyporesponsive to LPS stimu-
lation.
The host signaling cascades that occur following TLR liga-
tion involve a conserved cytoplasmic domain known as the
Toll/IL-1 receptor (TIR) domain (38). The TIR domain of
TLRs interacts with the adaptor proteins MyD88 and/or TI-
RAP, which subsequently recruits IL-1 receptor-associated ki-
nases (IRAKs) to the receptor (21, 30, 50). Once an IRAK
becomes activated, it dissociates from the receptor complex
and leads to the activation of TRAF-6, an event that facilitates
the downstream activation of I-B kinase (IKK) and p38 mi-
togen-activated protein (MAP) kinase via a Tak-dependent
mechanism (46, 49). The result of these signaling events is the
nuclear translocation and transactivation of NF-B, leading to
the production of proinflammatory mediators and the up-reg-
ulation of costimulatory molecules (29). In addition, the acti-
vation of TLR2 has been shown to activate a phosphatidylino-
sitol 3-kinase/Rac-1-dependent pathway, which leads to the
transactivation of NF-B by Akt (1).
In this study, we sought to definitively assess the role of LPS
and type 1 pili in the activation of bladder epithelial cells and
to clarify discrepancies in the literature by analyzing multiple
cell lines of uroepithelial origin. In contrast to the A498 cell
line, all of the bladder epithelial cell lines tested were respon-
sive to LPS. Furthermore, CD14 is expressed by bladder epi-
thelial cells and, together with TLRs, mediates cellular activa-
tion following challenge with type 1 piliated E. coli or LPS.
MATERIALS AND METHODS
Bacterial strains. E. coli AAEC185 transformed with the entire type 1 pilus
gene cluster (AAEC185/pSH2) or the type 1 pilus gene cluster minus the tip
adhesin FimH (AAEC185/pUT2002) was grown static in Luria broth for 48 h at
37°C to induce the expression of type 1 pili. Before all experiments, expression
of type 1 pili was confirmed by mannose-inhibitable yeast agglutination.
Cell culture. 5637 epithelial cells (derived from a bladder carcinoma; ATCC
HTB-9), T24 epithelial cells (derived from a bladder carcinoma; ATCC HTB-4),
J82 epithelial cells (derived from a bladder carcinoma; ATCC HTB-1), and A498
epithelial cells (derived from a kidney carcinoma; ATCC CRL-7908) were cul-
tured in RPMI medium (Gibco BRL, Carlsbad, Calif.) plus 10% fetal bovine
serum (FBS; Sigma, St. Louis, Mo.) at 37°C in a water-saturated atmosphere
containing 95% air and 5% CO2. THP-1 monocyte/macrophage cells (derived
from a monocytic leukemia; ATCC TIB-202) were cultured in RPMI medium
containing 10% FBS, 1.5 g of sodium bicarbonate/liter, 4.5 g of glucose/liter, 1
mM sodium pyruvate, and 0.05 mM 2-mercaptoethanol.
IL-6 stimulation assay. 5637, T24, J82, and A498 cells were seeded into
24-well plates at 0.3  105 to 1  105 cells per well and grown to confluence over
2 days. THP-1 cells were seeded into 24-well plates at 5  105 cells per well in
a medium containing 50 mM phorbol 12-myristate 13-acetate (PMA) and al-
lowed to differentiate for 2 days. Forty-eight-hour bacterial cultures were pel-
leted by centrifugation, resuspended in phosphate-buffered saline (PBS), and
diluted to a concentration of 108 CFU/ml (except for the dose curve experiments,
where multiple bacterial stock dilutions were generated). Ten microliters of the
bacterial suspension was added to appropriate wells containing 1 ml of fresh
medium to achieve a final bacterial concentration of 106 CFU/ml. Titers of
bacterial suspensions were determined at the outset of each experiment to verify
the number of live bacteria added to the wells. The bacteria were spun onto the
cells by low-speed centrifugation and incubated at 37°C for 6 h. After the
incubation, the supernatants were collected, cell debris and bacteria were re-
moved by centrifugation, and samples were frozen at 80°C until they were
assayed by using a human IL-6 sandwich enzyme-linked immunosorbent assay (R
& D Systems, Minneapolis, Minn.). A similar protocol was used for determining
the effects of IL-1, tumor necrosis factor alpha (TNF-) (R & D Systems), LPS
(Sigma), and the bacterial lipoprotein Pam3-Cys-Ser-Lys4-OH (Boehringer
Mannheim, Indianapolis, Ind.) on cellular activation.
Signaling inhibition studies. 5637 cells were preincubated with 10 M MG-
132 or 5 M SB203580 (both from Calbiochem, San Diego, Calif.) for 1 h, after
which the cells were either left unstimulated or treated with the indicated stim-
ulants. T24 cells were preincubated with 20 M MG-132 or 50 M SB203580 for
1 h, after which the cells were either left unstimulated or treated with the
indicated stimulants. Supernatants were analyzed as described above.
Immunohistochemistry. T24 cells were plated in 24-well plates on coverslips at
0.3  104 to 1  104 cells per well and were grown over 2 days. This lower cell
density was utilized in order to better evaluate individual cells. After stimulation,
cells were fixed with 3.7% paraformaldehyde–0.2% Triton X-100 in PBS for 10
min. After three 5-minute washes in PBS, coverslips were blocked with 1%
bovine serum albumin and 0.2% milk in PBS (PBS-BB) for 15 min. Coverslips
were then stained with 1 g of anti-NF-B p65 (BD Pharmingen, San Diego,
Calif.)/ml in PBS-BB overnight at 4°C. As a negative control, coverslips were
stained without a primary antibody. After three 5-min PBS washes, coverslips
were incubated with 3 g of Cy3-conjugated F(ab)2 donkey anti-mouse immu-
noglobulin G (IgG) (Jackson Immunoresearch Laboratories, West Grove,
Pa.)/ml for 1 h at room temperature.
CD14 inhibition. To block CD14-mediated responses, cells were preincubated
with My4 (Beckman-Coulter, Fullerton, Calif.), a monoclonal anti-CD14 anti-
body, at 5 g/ml or with the same concentration of a mouse IgG2b isotype
control (Sigma) for 30 min at 37°C. The cells were subsequently either left
unstimulated or treated with the indicated stimulants, and supernatants were
analyzed as described above.
Flow cytometry. Cell suspensions were prepared from confluent cells growing
as monolayers in T25 flasks and detached from the surface by using 0.02%
EDTA in PBS. Between 2.5  105 and 5  105 cells were stained with My4 or the
IgG2b isotype control at 5 g/ml. Subsequently, the samples were incubated with
biotinylated goat anti-mouse IgG (1:100) and finally phycoerythrin (PE)-conju-
gated streptavidin (1:600) (both from BD Pharmingen). Cells were analyzed by
using a FACScalibur flow cytometer, and 12,000 live cells from each sample were
collected. Data were analyzed by using Cell Quest software. The live cell popu-
lation was defined by using propidium iodide staining.
CD14 mRNA reverse transcription-PCR (RT-PCR). Following the protocol of
Funda et al. (8), total RNA was isolated from cultured cells with TRIzol (Gibco
BRL) according to the package protocol. No additional efforts were made to
remove genomic DNA. First-strand cDNA was prepared from 4 l of total RNA
product by using 200 U of Superscript II reverse transcriptase (Gibco BRL) in a
reaction mixture containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol, 1.5 M oligo(dT)12-18 primers, and 0.125 mM each
deoxynucleotide triphosphate (dNTP) at 42°C for 50 min, then 70°C for 15 min.
Three microliters of the cDNA product was subjected to PCR amplification with
2.5 U of Taq polymerase (Invitrogen, Carlsbad, Calif.) in a solution containing 10
mM Tris-HCl (pH 8.8), 50 mM KCl, 2 mM MgCl2, 0.2 mM each dNTP, and 0.8
mM each primer. Cycling parameters were as follows: 30 cycles of 94°C for 45 s,
57°C for 45 s, and 72°C for 2 min, followed by a 10-min final extension at 72°C.
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Primers for human CD14 (Invitrogen) were 5-GCTGTGTAGGAAAGAAGC
TA-3 (sense) and 5-TTTAGAAACGGCTCTAGGTTG-3 (antisense). Since
these primers span the single intron of the CD14 gene, expected product sizes are
356 bp from genomic DNA and 284 bp from mRNA (8). Primers for amplifica-
tion of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Invitrogen) were
5-TCATCTCTGCCCCCTCTGCT-3 (sense) and 5-CGACGCCTGCTTCAC
CACCT-3 (antisense), with an expected product size of 440 bp (from either
mRNA or genomic DNA). PCR products were run on 1.5% agarose gels stained
with ethidium bromide and viewed with a UV transilluminator.
LPS tolerance. LPS tolerance was induced in 5637 and T24 bladder epithelial
cells by incubating the cells with LPS from E. coli O55:B5 (Sigma) at 1 g/ml for
16 to 20 h at 37°C. Following the incubation, cells were washed with PBS (plus
Mg2 and Ca2), and fresh medium was added to the cells. Cells were subse-
quently either left unstimulated or treated with the indicated stimulants, and
supernatants were analyzed as described above.
RESULTS
LPS responsiveness is common to bladder epithelial cell
lines. Several studies using the A498 epithelial cell line as a
model system have argued that the uroepithelium is not re-
sponsive to LPS(9, 15). To test this hypothesis, multiple uro-
epithelial cell lines, including 5637 cells (bladder), T24 cells
(bladder), J82 cells (bladder), A498 cells (kidney), and THP-1
cells (macrophage/monocyte, differentiated with PMA), were
stimulated with LPS in log increments from 0.5 ng/ml to 5
g/ml. All of the bladder epithelial cell lines were capable of
responding to LPS, but the 5637 cells were significantly less
responsive than the other two bladder epithelial cell lines (Fig.
1). Both T24 and J82 bladder cells responded to LPS at con-
centrations as low as 0.5 ng of LPS/ml, with maximal responses
occurring at 5 g/ml and 5 ng/ml, respectively. The threshold
of activation for 5637 cells occurred at an LPS concentration
between 5 and 50 ng/ml. A498 cells, which have been shown to
respond poorly to soluble LPS, failed to produce IL-6 even
when stimulated with the highest concentration of LPS (3, 16).
PMA-differentiated THP-1 cells responded to LPS concentra-
tions as low as 0.5 ng/ml and reached their maximal response
FIG. 1. Bladder epithelial cells uniformly respond to LPS. 5637 (bladder), T24 (bladder), J82 (bladder), A498 (kidney), and THP-1 (monocyte/
macrophage) cells were stimulated with log increments of LPS between 0.5 ng/ml and 5 g/ml. Supernatant IL-6 concentrations were determined
6 h after the addition of LPS. Experiments were performed at least three times in triplicate.
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at 50 ng/ml. Thus, the bladder epithelial cell lines appear to be
uniformly LPS responsive, in contrast to the A498 cell line.
LPS responsiveness is correlated with cellular responses to
E. coli. The type 1 mannose-binding adhesin, FimH, is located
in specialized tip fibrillae found at the distal ends of pili (27).
The nonpiliated K-12 E. coli strain AAEC185 was transformed
with a plasmid encoding the type 1 pilus gene cluster (pSH2) or
with a fimH deletion variant of the type 1 plasmid (pUT2002).
To determine the relationship between responses to purified
LPS and to E. coli, T24, 5637, and A498 cells were stimulated
with FimH or FimH E. coli at doses of bacteria ranging
from 103 to 107 CFU/ml in log increments. T24 cells were
activated at doses of E. coli as low as 103 CFU/ml, 5637 cells at
a dose of 105 CFU/ml, and A498 cells at a dose of 106 CFU/ml
(Fig. 2). At the lower doses of bacteria, FimH and FimH E.
coli strains elicited similar levels of IL-6 production from either
T24 or 5637 cells; however, at approximately 106 CFU/ml,
FimH E. coli stimulated significantly more cytokine than did
its isogenic FimH counterpart (Fig. 2). In A498 cells, FimH
E. coli stimulated substantially more IL-6 at 106 CFU/ml than
the FimH strain or the nonpiliated strain; however, these
differences were less prominent at bacterial doses of 107
CFU/ml (Fig. 2 and data not shown). IL-6 production was
decreased in all cell lines if more than 107 CFU of E. coli/ml
was used to stimulate the cells (data not shown). Thus, the
threshold of activation following E. coli challenge directly cor-
relates with the LPS responsiveness of the cell type (Fig. 1 and
2). In contrast, cellular stimulation with FimH E. coli char-
acteristically leads to an increase in IL-6 production at 106
CFU/ml irrespective of the baseline LPS responsiveness of the
cell type. The observation that the expression of adhesive
(FimH) type 1 pili did not shift the threshold of activation for
these uroepithelial cell lines is consistent with previous reports
demonstrating that type 1 pilus-mediated invasion augments
bladder epithelial responses at this bacterial dose (44). FimH
E. coli binds and invades T24, 5637, and A498 cells to equiv-
alent levels (data not shown).
NF-B and p38 MAP kinase activation is required for blad-
der epithelial responses to LPS and E. coli. The production of
IL-6 following LPS stimulation generally involves the activa-
tion of NF-B and p38 MAP kinase; however, NF-B-inde-
pendent pathways have been described (5). Stimulation of T24
bladder cells with type 1 piliated E. coli led to a redistribution
of NF-B p65 from the cytoplasm to the nucleus, consistent
with the activation of this transcription factor (Fig. 3a and b).
Proteasome inhibitors have been shown to block NF-B trans-
location to the nucleus by preventing the degradation of IB
(39), whereas p38 MAP kinase inhibitors appear to block the
transactivation of NF-B in the nucleus (46). Preincubation of
T24 bladder cells with the proteasome inhibitor MG-132
blocked NF-B p65 translocation and IL-6 production follow-
ing challenge with FimH E. coli (Fig. 3c and e). Preincubation
of bladder cells with the p38 MAP kinase inhibitor SB203580
blocked IL-6 production despite translocation of NF-B p65 to
the nucleus (Fig. 3d and e). Similar results were observed when
5637 cells infected with FimH E. coli were pretreated with
these inhibitors (Fig. 3f). As expected, both inhibitors blocked
bladder cell IL-6 responses to IL-1 and LPS (data not shown).
These results argue that the nuclear translocation of NF-B
and the activation of p38 MAP kinase-dependent signal trans-
duction cascades are required for the induction of bladder
epithelial IL-6 following stimulation with inflammatory mole-
cules and E. coli.
Bladder epithelial cells express CD14 on their surfaces.
CD14 is a major component of the LPS receptor complex on
macrophages; however, several reports have stated that this
FIG. 2. Uroepithelial responses to E. coli directly correlate with
LPS responsiveness. T24 (high LPS responder), 5637 (intermediate
LPS responder) and A498 (low LPS responder) cells were infected
with increasing concentrations of FimH (filled circles) or FimH
(open circles) E. coli. Open squares, constitutive IL-6 production. IL-6
levels in the supernatant were determined 6 h after infection. Exper-
iments were performed at least three times in triplicate.
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molecule is not involved in uroepithelial responses to E. coli
(15, 47). Given the data implicating LPS recognition in bladder
epithelial cytokine responses, uroepithelial expression of cell
surface CD14 was evaluated. To assess CD14 expression, 5637,
T24, J82, A498, and PMA-differentiated THP-1 cells were an-
alyzed by flow cytometry using the well-characterized anti-
CD14 monoclonal antibody My4. The results showed a clear
My4-mediated fluorescence shift over the fluorescence level
observed with the isotype control antibody in 5637, T24, and
J82 cells (Fig. 4). In contrast, no significant fluorescence shift
was detected with A498 cells. The positive control THP-1 cells
also showed a significant induction of CD14 cell surface ex-
pression following PMA differentiation, as has been previously
reported (10). The relative level of CD14 on the cell surface
FIG. 3. Activation of NF-B and p38 MAP kinase is required for bladder epithelial cytokine responses to E. coli. (a through d) Immunohis-
tochemical staining (in red) for the p65 subunit of NF-B is shown in the upper panels, and differential interference microscopy is shown in the
lower panels. (a) NF-B in unstimulated T24 cells is localized to the cytoplasm. (b) After stimulation with type 1 piliated E. coli, NF-B is
translocated to the nuclei of T24 cells. AAEC185/pUT2002 (FimH) also induces nuclear localization (data not shown). (c) Preincubation of T24
cells with MG-132 inhibits nuclear localization of NF-B in response to E. coli. (d) Preincubation with the p38 MAP kinase inhibitor SB203580
does not inhibit NF-B translocation. (e and f) T24 and 5637 cell responses to FimH or FimH E. coli (solid bars) are blocked by preincubation
with MG-132 (open bars) or SB203580 (shaded bars).
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was estimated by determining the fold induction of My4-me-
diated fluorescence over the antibody isotype control fluores-
cence level (the geometric means of the fluorescence intensi-
ties were used for this purpose). Notably, cell lines of higher
LPS responsivity had the most mCD14 by fluorescence-acti-
vated cell sorting (FACS) (J82, ratio 9.1; T24, 7.1; THP-1 [plus
PMA], 4.9), the intermediate LPS responder cell line had
lower levels of CD14 (5637, 3.4), and the LPS-hyporesponsive
cell line had undetectable levels of CD14 (A498, 1.08) (Fig. 4).
Thus, three independent bladder epithelial cell lines express
FIG. 4. Bladder epithelial cell lines express mCD14. Expression of CD14 was assessed by indirect immunofluorescence using the anti-CD14
monoclonal antibody My4 (open histograms) or the IgG2b isotype control antibody (shaded histograms). The fluorescence signal was amplified
by using a biotinylated goat anti-mouse secondary antibody followed by PE-conjugated streptavidin. Relative CD14 expression is shown (lower
right graph) as fold induction in mean fluorescence for My4-stained cells, by using the isotype control-stained cells as the baseline fluorescence
value.
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mCD14, in contrast to previous suggestions that uroepithelial
cells are CD14 negative (17). Bladder cells are capable of
endogenous CD14 production; RT-PCR analysis of total RNA
from 5637, T24, and J82 bladder cells demonstrated the pres-
ence of CD14 mRNA, by using differentiated THP-1 cells as a
positive control (Fig. 5). CD14 transcript was also detectable in
A498 cells.
CD14 is required for bladder epithelial cell responses to
LPS and E. coli. The presence of CD14 on the surfaces of
bladder epithelial cells argues that this receptor likely plays a
role in the recognition of E. coli and LPS by this cell type. To
assess the contribution of CD14 to bladder cytokine responses,
5637, T24, or J82 cells were preincubated with My4 or the
isotype control antibody at 5 g/ml for 30 min. Subsequently,
the cells were stimulated with increasing concentrations of LPS
ranging from 0.5 ng/ml to 5 g/ml. The response to LPS in each
of these bladder cell lines was inhibited by My4, indicating an
important role for CD14 in bladder epithelial cell recognition
of LPS. To determine the role of CD14 in the cellular response
to E. coli, 5637 cells were either left unstimulated or stimulated
with either IL-1, LPS (500 ng/ml), or FimH or FimH E.
coli. My4 had no effect on unstimulated or IL-1-stimulated
cells but significantly reduced IL-6 production induced by LPS
(65% inhibition), AAEC185/pUT2002 (FimH) (89% inhibi-
tion), or AAEC185/pSH2 (FimH) (77% inhibition) (Fig. 6).
My4 had no effect on binding or invasion by AAEC185/pSH2
(data not shown).
Activation of bladder epithelial cells requires TLR signal-
ing. TLRs are pathogen pattern recognition receptors that
recognize a variety of pathogen-associated molecular products
(PAMPs), including LPS, and initiate the activation of NF-B
and p38 MAP kinase. Therefore, TLRs would be predicted to
be important signaling receptors in bladder epithelial cells,
which have been shown to express tlr4 and tlr2 mRNA (3, 44).
Ba¨ckhed et al. transiently transfected a dominant-negative
TLR4 construct into T24 cells and observed a modest decrease
in LPS responsiveness (2). Prestimulation of macrophages with
LPS renders them refractory to subsequent LPS stimulation, a
phenomenon termed LPS tolerance. Though the precise mo-
lecular mechanism of LPS tolerance is unclear, it has been
shown that LPS-tolerant macrophages have decreased TLR4
surface expression and also fail to activate IRAKs following
LPS restimulation (34, 37). Cross-tolerance between IL-1 and
LPS has been demonstrated, adding further support to the idea
that LPS tolerance is the consequence of disrupted TIR do-
main-mediated signaling (33, 34). To further address the role
of TLR signaling in bladder epithelial responses, we investi-
gated the ability of 5637 bladder cells to become tolerant to
LPS stimulation.
To induce tolerance, bladder epithelial cells were incubated
with LPS for 16 to 20 h, after which time the cells were washed
and either left unstimulated or stimulated with IL-1, TNF-,
LPS, or bacterial lipoprotein (LPP). 5637 cells had defective
responses to IL-1 (60% inhibition), LPS (87% inhibition),
and LPP (94% inhibition) following tolerance induction (Fig.
7a). However, the responses to TNF- were unaffected in
tolerant 5637 cells. These results demonstrate that LPS toler-
ance can be induced in bladder epithelial cells and argue that
LPS-tolerant 5637 cells have a defect in the MyD88/IRAK
pathway, as this signaling pathway is shared by IL-1R and
TLRs but not by TNF receptors.
The effect of LPS tolerance and the accompanying TLR
signaling defect on the responses of 5637 and T24 bladder cells
to type 1 piliated E. coli was determined. Following induction
of LPS tolerance, 5637 and T24 cells produced significantly
lower levels of IL-6 in response to FimH or FimH E. coli,
arguing that TLR signaling is required for epithelial activation
in response to infection (Fig. 7b and c). Binding and invasion
by the FimH strain of E. coli was unaffected by the induction
of LPS tolerance (data not shown).
DISCUSSION
The role of LPS in the activation of uroepithelial cells has
been a controversial area of research. Several reports have
claimed that uroepithelial cells are refractory to LPS stimula-
tion and have argued that, instead, bacterial pili, such as the
type 1 pilus, drive the induction of cytokines in these cells (47).
In contrast, other studies have suggested an important role for
LPS in the stimulation of bladder epithelial cells by type 1
piliated E. coli (3, 44). The data arguing against a role for LPS
in uroepithelial cell activation have come largely from investi-
gations utilizing the A498 kidney epithelial cell line as a model
of the uroepithelium (15). To clarify the controversy over the
role of LPS in bladder epithelial cell activation and to assess
the molecular basis of bladder cell responses, we compared
three bladder epithelial cell lines to the A498 cell line with
respect to their responses to LPS and type 1 piliated E. coli.
In this study, 5637 (bladder), T24 (bladder) and J82 (blad-
der) cells were all shown to respond to LPS, whereas A498
cells (kidney) failed to respond to even the maximal dose of
LPS tested. The ability to recognize LPS directly correlated
with the production of IL-6 following challenge with both
FimH and FimH E. coli. Specifically, the threshold of acti-
vation for the LPS-hyporesponsive A498 cells by E. coli was
1,000 times and 10 times higher than it was for T24 and 5637
FIG. 5. Uroepithelial cells contain CD14 transcript. (A) RT-PCR
amplification of total RNA from 5637, T24, and J82 cells demonstrates
CD14 products, from both mRNA (284 bp) and from genomic DNA
(356 bp). Omission of reverse transcriptase (RT) in the reaction mix-
ture results in the absence of the mRNA-related band. A498 cells also
contain CD14 transcript. PMA-differentiated THP-1 cells were used as
a positive control. (B) Amplification of the GAPDH sequence was
utilized to generally relate the amounts of mRNA used in the CD14
RT-PCR experiments. The 440-bp band arises from both mRNA and
genomic DNA. All amplifications, including reverse transcriptions,
were performed at least three times.
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bladder cells, respectively. This is consistent with previous re-
ports arguing that T24 and 5637 cells recognize and respond to
LPS on the surfaces of type 1 piliated E. coli cells (3, 44). At a
stimulatory dose of 106 CFU/ml, FimH-expressing E. coli en-
hanced IL-6 production from the uroepithelial cell lines over
production with the isogenic FimH mutant strain. This aug-
mentation has been shown previously to be a consequence
of type 1 pilus-mediated bacterial invasion (44). However,
FimH bacteria still activate a significant IL-6 response in
5637, T24, and A498 cells, indicating that functional (adhesive)
type 1 pili are not required to induce such a response. It is not
known which bacterial product(s) is recognized by A498 cells;
however, the present data would suggest that LPS may not
mediate the activation of these cells (7). It is possible that the
lack of a functional LPS receptor complex in A498 kidney cells
unmasks the stimulatory capacity of other bacterial molecules,
as has been demonstrated using a lipid A mutant strain of
Neisseria meningitidis (25, 41).
The present data support the model that bladder epithelial
cell lines are LPS responsive and that the ability to recognize
LPS is a critical event in the induction of innate responses
against FimH and FimH E. coli. In macrophages, the pri-
mary host cell receptor complex for LPS consists of mCD14
and TLR4/MD-2, which lead to the activation of p38 MAP
kinase and the nuclear translocation of the transcription factor
NF-B (35, 38). It has been proposed that epithelial cells
recognize pathogens through pathways that are fundamentally
different from those in macrophages (9, 40). Moreover, if one
FIG. 6. CD14 is required for optimal bladder epithelial cytokine responses to LPS and type 1 piliated E. coli. T24 (a) and J82 (b) bladder
epithelial cells were preincubated for 30 min with an isotype control antibody (filled bars) or the anti-CD14 antibody My4 (open bars) at 5 g/ml.
IL-6 production was determined 6 h after stimulation with LPS at 0.5, 5, or 50 ng/ml. (c) 5637 cells require higher doses of LPS to generate IL-6
responses, but these responses are similarly inhibited by an anti-CD14 antibody. (d) Antibody-treated 5637 cells were challenged with 10 ng of
IL-1/ml, 500 ng of LPS/ml, or 106 CFU of AAEC185/pUT2002 (FimH) or AAEC185/pSH2 (FimH)/ml. The IL-1 response is independent
of CD14 activity, but responses to bacteria were blocked by My4. Experiments were performed at least three times in triplicate.
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were to assume (based on examination of the A498 cells alone)
that uroepithelial cells do not express mCD14 or utilize sCD14
for anti-E. coli responses, then an alternate pathway for LPS
recognition would have to exist (9, 17, 47).
To define the LPS receptor complex utilized by bladder
epithelial cells, the signal transduction cascades leading to IL-6
production were investigated. Stimulation of bladder epithelial
cells with E. coli led to the nuclear translocation of NF-B p65.
In addition, preincubation of bladder epithelial cells with the
proteasome inhibitor MG-132 (which blocks NF-B trans-
location) or with the p38 MAP kinase inhibitor SB203580
completely blocked the induction of IL-6 following bacterial
challenge. These findings demonstrate a role for these signal
transduction cascades in the activation of bladder epithelial
cells by LPS on type 1 piliated E. coli.
To further characterize the receptors involved in the gener-
ation of LPS-mediated responses, the expression and role of
CD14 were evaluated. The responses of 5637, T24, and J82
bladder epithelial cell lines to LPS were inhibitable with the
monoclonal anti-CD14 blocking antibody My4, demonstrating
that CD14 is a component of the LPS receptor complex on all
of these bladder cell lines. It was also shown that bladder
epithelial responses to FimH and FimH E. coli require
CD14. Cell surface expression of CD14 was shown by using
flow cytometry with an anti-CD14 antibody for 5637, T24, and
J82 bladder cells; however, consistent with previous results,
A498 cells did not express CD14 (17). RT-PCR analysis con-
firmed the presence of CD14 mRNA in all three bladder ep-
ithelial cell lines. In contrast, Ba¨ckhed et al. were unable to
demonstrate amplification of CD14 mRNA from T24 cells (2).
The reason for this discrepancy is unclear, but it may result
from growth conditions or cell passage number, as CD14 ex-
pression on human nonmyeloid cells in vitro has been shown to
decrease with time in culture (26). Since our functional exper-
iments were performed in the presence of serum, a role for
sCD14 in contributing to the activation of these mCD14-ex-
pressing cells cannot be excluded, although no CD14 was de-
tected on the surfaces of A498 kidney cells. In addition, our
bladder cell cultures for flow cytometry and RT-PCR con-
tained no LPS, and sCD14 has been shown to require the
presence of LPS in order to bind to the surface of CD14-
negative nonmyeloid cells (48). Thus, our data argue that at
least a portion of the surface CD14 on bladder cells is likely to
be endogenously produced.
TLRs are pathogen pattern recognition receptors that play a
critical role in innate immunity. TLR4 and TLR2 have been
implicated in LPS recognition by macrophages, but other cell
types also express these receptors, including 5637 and T24
bladder epithelial cells (3, 44). LPS tolerance is a phenomenon
first described for macrophages where following a prestimula-
tion with low to intermediate concentrations of LPS, cells
become refractory to a second LPS stimulation. The current
understanding of LPS tolerance would argue that the primary
mechanism underlying the nonresponsiveness of tolerant cells
is the disruption of signal transduction cascades initiated by
TIR domain-containing receptors, potentially superimposed
on a loss of TLR4 expression on the cell surface (37). Bladder
epithelial cells that were prestimulated with LPS had signifi-
cantly reduced responses to IL-1, LPS, and LPP but had
normal responses to TNF-. These results demonstrate that
LPS tolerance can be induced in uroepithelial cells. Further-
more, the observation that the response to TNF- is unaffected
in LPS-tolerant cells indicates that the cells are not globally
suppressed but instead have a specific signaling defect that
maps to TIR domain-containing receptors (such as TLRs) or
early downstream signaling molecules. When LPS-tolerant
bladder cells were stimulated with FimH or FimH E. coli,
FIG. 7. Toll-like receptors mediate bladder epithelial recognition
of LPS and type 1 piliated E. coli. (a) 5637 cells were prestimulated
with medium alone (filled bars) or 1 g of LPS/ml (open bars) and
were subsequently challenged with 10 ng of IL-1/ml, 10 ng of TNF-
/ml, 500 ng of LPS/ml, or 500 ng of LPP/ml. (b) LPS-tolerant or
nontolerant 5637 cells were challenged with 10 ng of TNF-/ml or 106
CFU of AAEC185/pUT2002 (FimH) or AAEC185/pSH2 (FimH)/
ml. (c) LPS-tolerant or nontolerant T24 cells were challenged with 10
ng of TNF-/ml or 103 CFU of AAEC185/pUT2002 or AAEC185/
pSH2/ml. Experiments were performed at least three times in tripli-
cate.
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IL-6 production by these cells was significantly inhibited. These
data argue that bladder epithelial activation following bacterial
stimulation is mediated by TLR activation, consistent with the
findings of Ba¨ckhed et al. (2).
Since signaling via multiple TLRs is likely rendered non-
functional in the LPS-tolerant state, it is not possible to con-
clusively state which member(s) of this receptor family medi-
ates E. coli recognition on bladder epithelial cells. However,
the importance of LPS for bladder epithelial cytokine re-
sponses, the inability of C3H/HeJ mice (TLR4 mutant) to
effectively clear E. coli-induced bladder infections, and the
effect of the dominant-negative TLR4 mutant demonstrated by
Ba¨ckhed et al. (2) suggest that TLR4 is critical in E. coli
recognition (20, 44). TLR2 has also been implicated in the
recognition of LPS and its associated lipoproteins, suggesting a
potential role for this receptor as well (19). To more closely
mimic the LPS that would be encountered by host cells in-
fected with whole bacteria, the LPS used in this study was not
repurified to eliminate the trace lipoproteins that are inti-
mately associated with commercially purified LPS preparations
(18). Thus, it is possible that TLR2 activation is contributing to
the LPS-driven stimulation we observed in bladder epithelial
cells, particularly at higher doses of LPS. Ongoing studies aim
to determine the respective roles of TLR4 and TLR2 in blad-
der epithelial responses to LPS and E. coli.
Epithelial cells are uniquely positioned to coordinate early
host defenses against invading pathogens. However, in order to
study the contribution of epithelial activation to the innate
immune response, the molecules utilized by these cells to rec-
ognize pathogens must be defined. Significant progress has
been made in understanding these details by using in vitro
uroepithelial cell systems. However, this study further illus-
trates the fact that cell cultures are an imperfect representation
of the in vivo epithelium and that it is often difficult to deter-
mine which, if any, of the cell lines provides the best represen-
tation of the in vivo epithelial surface. In this analysis, we
utilized three independent bladder epithelial cell lines to gain
a more comprehensive understanding of bladder epithelial re-
sponses to LPS and E. coli. The data from this investigation
demonstrated that all of these bladder cell lines are LPS re-
sponsive and that this response is facilitated by the activation
of NF-B and p38 MAP kinase through a CD14–TLR com-
plex. The present data are consistent with those of Ba¨ckhed et
al. showing a role for TLR4 in LPS responsiveness in bladder
epithelial cells. Also, the significantly impaired ability of C3H/
HeJ mice to clear an experimental bladder infection (12, 20,
44) and a recent report that the murine bladder mucosa ex-
presses numerous inflammatory genes following LPS challenge
in vivo (43) are consistent with our findings. Thus, we argue
that the bladder mucosal surface is primed to recognize and
respond to LPS. In contrast, the A498 cell line is hyporespon-
sive to LPS and substantially less efficient at producing anti-E.
coli responses than the bladder cell lines. Based on these re-
sults, we suggest that the bladder epithelium should be con-
sidered a CD14-expressing, LPS-responsive entity that is not
accurately depicted by the A498 cell line. Alternatively, pub-
lished results with the A498 cell line may in fact argue that
there are fundamental differences in innate responses of blad-
der and kidney epithelia, as has been proposed by Ba¨ckhed et
al. (3). Future studies using in vivo analysis and primary cell
lines will help to further characterize CD14–TLR interactions
and bladder epithelial responses to UPEC during an acute
urinary tract infection. The methods employed here may be
applied to other epithelial cell types to determine whether the
CD14–TLR receptor complex is employed by these epithelia to
recognize and respond to LPS.
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